INS and type 1 diabetes mellitus: One study looked at T1D patients with DKA and found BM-MSCs to preserve β-cell function in T1D patients, reducing levels of fasting and post-prandial C-peptide levels, with one patient achieving insulin independence for a period of three months [57].